Term
|
Definition
A general term for drugs, chemicals, or other
substances that either kill or slow the growth of microbes.
|
|
|
Term
|
Definition
A drug used to treat infections caused by bacteria and
other microorganisms. Includes synthetically produced drugs
|
|
|
Term
|
Definition
a compound that inhibits growth or reproduction of a
microorganism, but does not directly kill the organism.
|
|
|
Term
|
Definition
capable of killing bacteria outright. |
|
|
Term
|
Definition
a drug that is administered in an inactive form. Activation
occurs in vivo upon it being metabolized. (e.g. Isoniazid is activated by
Mycobacterium’s catalase enzyme)
|
|
|
Term
Broad-spectrum antibiotics |
|
Definition
capable of targeting both Gram-
negative and Gram-positive bacteria.
|
|
|
Term
Antimicrobial Sensitivity Assays: Kirby‐Bauer Disc Diffusion |
|
Definition
Qualitative measurement of Minimum Inhibitory Concentration (MIC) |
|
|
Term
Determining Quantitative Minimal Inhibitory Concentration (MIC) |
|
Definition
Commercially available strips.
Serial dilution of antibiotic
across strip. Placed on agar
plate containing bacteria. View
edge of clearing at lowest
concentration of antibiotic.
|
|
|
Term
Determining Minimal Bactericidal Concentration (MBC) |
|
Definition
Inoculate from MIC cultures
into fresh growth medium
lacking antibiotics
MBC will always be greater-
than or equal-to MIC.
|
|
|
Term
Antibiotics targeting cell wall biosynthesis |
|
Definition
Fosfomycin, Ramoplanin, Mersacidin, Moenomycin, Chlorobiphenylvancomycin, Vancomycin, Penicillin, Cephalosporin, Bacitracin, Carbapenems
Cycloserine, vancomycin, bacitracin, fosfomycin, penicillins, cephaolosporin, carbapenems |
|
|
Term
Antiobiotics that target protein synthesis |
|
Definition
Macrolides, Lincosamides, Streptogramins, Everninomycins, Oxazolidones (50s)
Aminoglycosides, Tetracyclines (30s)
50s - erythromycin, chloramphenicol, clindamycin
30s - tetracycline, spectinomycin, streptomycin, gentamicin, tobramycin, amikacin |
|
|
Term
Antiobiotics that target DNA replication/RNA synthesis |
|
Definition
Rifampin, Ciprofloxacin, Novobiocins
nalidixic acid, quinolines (DNA gyrase)
rifampin (DNA dependent RNA polymerase) |
|
|
Term
|
Definition
Sulfamethoxazole, Trimethoprim
Structural analogs and competitive antagonists to PABA and dihydrofolate
TMP+SMX = bactrim
work synergistically to block different steps in same pathway that is used for folate metabolism/thymine biosynthesis |
|
|
Term
|
Definition
Lipopolysacharide (LPS), polymyxin B, E
cyclic peptide binds LPS and hydrophobic tail interacts with membrane to form pore |
|
|
Term
Beta Lactams
(penicillin, cephalosporin) |
|
Definition
|
|
Term
Ampicillin
(amino penicillin) |
|
Definition
A beta lactam - penicillin with altered R group that allows it to target a wider range of bacterial species
Broad gram negative coverage, enterococci |
|
|
Term
Penicillinase resistant (IV) |
|
Definition
Nafcillin, Oxacillin
use penicillinase resistant antibiotics for staphylococcal skin infections when suspect that staph produces Beta-lactamase |
|
|
Term
Penicillinase resistant (oral) |
|
Definition
Cloxacillin, Dicloxacillin |
|
|
Term
|
Definition
Ticarcillin, Piperacillin
anaerobic coverage |
|
|
Term
|
Definition
IV or IM (cannot survive stomach acid)
Group A strep, syphilis, listeria, neisseria meningitidis, streptococcus pneumoniae |
|
|
Term
|
Definition
Oral administration (acid resistant)
Strep throat |
|
|
Term
Combined penicillin and beta lactamase inhibitors |
|
Definition
Augmentin (amoxicillin + clavulanate)
Timentin (ticarcillin + clavulanate), Unasyn, Zosyn
Augmentin is oral, others are IV
Very broad coverage, anaerobic coverage |
|
|
Term
Key points to remember for penicillins |
|
Definition
1. Can cause allergenic reactions and lead to superinfections
2. Not all are resistant to stomach acid, some given IV.
3. Non-MRSA and GAS infections can be treated with Nafcillin and
Dicloxacillin
4. Anti-pseudomonal drug of choice is Ticarcillin (contains β-lactamase
inhibitor).
5. Augmentin is another combinatorial drug (Amoxacillin + clavulanic
acid)
|
|
|
Term
|
Definition
Benefits over penicillin: more resistant to lactamases, R2 group offers more manipulation for changing specificity (2 R groups on penicillin ring)
|
|
|
Term
1st generation cephalosporins |
|
Definition
Best for gram positives (strep and staph)
Cefazolin |
|
|
Term
2nd generation cephalosporins |
|
Definition
broader Gram-negative spectrum; respiratory tract infections, sinusitis
and otitis media; urinary tract infections from E. coli, Klebsiella and Proteus
Cefprozil, cefuroxime, cefaclor, cefaxitin |
|
|
Term
3rd generation Cephalosporins |
|
Definition
further increased effectiveness against Gram-negatives, but decreased
against many Gram-positives (exception Streptococcus pneumoniae - Ceftriaxone)
Best for gram-negatives
|
|
|
Term
4th generation Cephalosporins |
|
Definition
Broadest coverage against Gram-negatives and positives; best
resistance to β-lactamases; some can cross blood-brain barrier (treat meningitis)
Cefquinome, Cefpirome, Cefozopran, Cefluprenam |
|
|
Term
Problems with Cephalosporins |
|
Definition
Many not effective against most hospital acquired infections:
• Clostridium difficile (C.dif)
• Methicillin Resistant Staphylococcus aureus (MRSA)
• Vancomycin Resistant Enterococcus (VRE)
• β-lactam resistant Streptococcus pneumoniae
|
|
|
Term
|
Definition
(Imipenem)
Very small β-lactam. Broadest antibacterial
coverage. Often given with cilastin (inhibitor of liver enzyme that breaks down this
drug)
Making it small allows to get into smaller pores at the cell wall in gram-negatives
|
|
|
Term
|
Definition
Great against Gram-negatives. Broad spectrum
when given with vancomycin or clindomycin.
cell wall inhibitor
|
|
|
Term
|
Definition
Topical use only, cyclic peptide (not a beta lactam) |
|
|
Term
|
Definition
Glycopeptide
MRSA, C diff, VRE |
|
|
Term
|
Definition
Cell wall inhibitor
used against mycobacterium tuberculosis (MTB)
inhibits synthesis of mycolic acid in cell wall |
|
|
Term
|
Definition
Used against mycobacterium tuberculosis as a second line drug
cell wall inhibitor |
|
|
Term
Target 50s ribsomal subunit |
|
Definition
Chloramphenicol: toxicity is severe (aplastic anemia). Not used in U.S. except topically or eye drops. Macrolides: (Erythromycin, Azithromycin) good against Gram-positives and negatives; low toxicity. Clindamycin: covers Anaerobes and Gram-positives, not negatives Linezolid (zyvox): best against MRSA and VRE. Very expensive. Streptogramins (combination drug quinupristin+dalfopristin); last choice drug due to high occurance of toxicity. |
|
|
Term
|
Definition
Tetracyclines (doxycycline, minocycline); chelates Ca2+; treats Chlamydia, tick-borne disease, acne; phototoxic
Spectinomycin: treats gonorrhea |
|
|
Term
Target 30s and 50s subunits |
|
Definition
Aminoglycosides: (Streptomycin, Gentamycin, Tobramycin, Amikacin). Renal
and cochlear toxicity at high rates.
|
|
|
Term
Target nucleic acid biosynthesis |
|
Definition
Trimethoprim/sulfamethoxazole (TMP/SMX)= Sulfa drugs. Treats UTIs and Pneumocystis carinii in AIDS patients. Quinolones/fluoroquinolones (ciprofloxacin): treat UTIs, lower respiratory infections, many Gram-negatives. Rifampin: treats carriage of Haemophilus influenza B (Hib) and Neisseria meningitidis |
|
|
Term
|
Definition
Targets cell membrane, topical treatment only
treats skin, ear, and eye infections
high toxicity if ingested |
|
|
Term
Combination anti-microbial therapy
Synergistic |
|
Definition
Combination use of 2 antibiotics reduces the MIC of either alone
Penicillin and aminoglycosides |
|
|
Term
Combination anti-microbial therapy
Additive |
|
Definition
decreasing concentration of drugs (due to toxicity) may be applied
if two different drugs are administered.
|
|
|
Term
Combination antimicrobial therapy
Antagonistic |
|
Definition
(reduction of activity of one or both)
Penicillin and Erythromycin or tetracycline (if you inhibit protein
synthesis (i.e. erythromycin) cell wall synthesis stops. Penicillin only
works on growing bacteria.
|
|
|
Term
Mechanisms of bacterial antibiotic resistance |
|
Definition
1. Alteration of bacterial protein targets (ribosomes, cell wall precursors 2. Alteration of bacterial membrane (physical barrier) - changing permeability of membrane keeps out larger molecules (gram negative resistance to B lactams) 3. Enzymatic inhibition of antibiotic (beta lactamases, aminoglycosidases) 4. Bypass pathways targeted by antibiotics - acquire metabolite from environment instead of synthesizing it (trimethoprim resistance if acquire thymidine from host instead of synthesizing) 5. Efflux of antibiotics from bacterial cell - pump out toxic compound (tetracyline efflux common in staphylococcus and pseudomonas |
|
|
Term
Means of acquiring bacterial resistance |
|
Definition
1. Single BP mutations 2. Large DNA rearrangements 3. Horizontal gene transfer (conjugation, bacteriophage transfer, endocytosis of exogenous DNA) |
|
|
Term
Indiscriminate use of antibiotics leads to: |
|
Definition
toxic effects, allergic reactions, antibiotic resistance, alteration of immune response, imbalance of normal body flora (opens up to disease by opportunistic infections that recolonize - candida albicans (oral and vaginal), C diff (GI)) |
|
|